Arkolith/Insider Trading/RPTX/Form 4

Segal Lloyd Mitchell

President and CEO, DirectorRepare Therapeutics Inc. (RPTX) · full profile →Form 4 · filed Feb 1, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 30, 2023Grant(A)79K—$085K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 30, 2023Grant(A)344K—$0344K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-006062) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML